Alsheikh-Ali AA - Search Results

1

Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy.

Jafri H, Alsheikh-Ali AA, Karas RH. Jafri H, et al. J Am Coll Cardiol. 2010 Jun 22;55(25):2846-54. doi: 10.1016/j.jacc.2009.12.069. J Am Coll Cardiol. 2010. PMID: 20579542 Free article. Review.

2

Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose).

Alsheikh-Ali AA, Abourjaily HM, Karas RH. Alsheikh-Ali AA, et al. Am J Cardiol. 2002 Jun 1;89(11):1308-10. doi: 10.1016/s0002-9149(02)02334-2. Am J Cardiol. 2002. PMID: 12031736 No abstract available.

3

Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin.

Abourjaily HM, Alsheikh-Ali AA, Karas RH. Abourjaily HM, et al. Am J Cardiol. 2003 Apr 15;91(8):999-1002, A7. doi: 10.1016/s0002-9149(03)00124-3. Am J Cardiol. 2003. PMID: 12686348 No abstract available.

4

17-beta-estradiol increases cardiac remodeling and mortality in mice with myocardial infarction.

van Eickels M, Patten RD, Aronovitz MJ, Alsheikh-Ali A, Gostyla K, Celestin F, Grohe C, Mendelsohn ME, Karas RH. van Eickels M, et al. J Am Coll Cardiol. 2003 Jun 4;41(11):2084-92. doi: 10.1016/s0735-1097(03)00423-6. J Am Coll Cardiol. 2003. PMID: 12798586 Free article.

5

Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones.

Alsheikh-Ali AA, Karas RH. Alsheikh-Ali AA, et al. Am J Cardiol. 2004 Jun 1;93(11):1417-8, A9. doi: 10.1016/j.amjcard.2004.02.045. Am J Cardiol. 2004. PMID: 15165929

6

Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.

Alsheikh-Ali AA, Wang PJ, Rand W, Konstam MA, Homoud MK, Link MS, Estes NA 3rd, Salem DN, Al-Ahmad AM. Alsheikh-Ali AA, et al. Am Heart J. 2004 Jun;147(6):1061-5. doi: 10.1016/j.ahj.2003.12.033. Am Heart J. 2004. PMID: 15199356

7

Risk of adverse events with fibrates.

Alsheikh-Ali AA, Kuvin JT, Karas RH. Alsheikh-Ali AA, et al. Am J Cardiol. 2004 Oct 1;94(7):935-8. doi: 10.1016/j.amjcard.2004.06.033. Am J Cardiol. 2004. PMID: 15464682

8

Adverse events with concomitant amiodarone and statin therapy.

Alsheikh-Ali AA, Karas RH. Alsheikh-Ali AA, et al. Prev Cardiol. 2005 Spring;8(2):95-7. doi: 10.1111/j.1520-037x.2005.4060.x. Prev Cardiol. 2005. PMID: 15860984 Free article.

9

High-density lipoprotein cholesterol in the cardiovascular equation: does the "good" still count?

Alsheikh-Ali AA, Kuvin JT, Karas RH. Alsheikh-Ali AA, et al. Atherosclerosis. 2005 Jun;180(2):217-23. doi: 10.1016/j.atherosclerosis.2005.01.003. Atherosclerosis. 2005. PMID: 15910846 Review.

10

The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis.

Alsheikh-Ali AA, Ambrose MS, Kuvin JT, Karas RH. Alsheikh-Ali AA, et al. Circulation. 2005 Jun 14;111(23):3051-7. doi: 10.1161/CIRCULATIONAHA.105.555482. Epub 2005 May 23. Circulation. 2005. PMID: 15911706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

203 results

Search Page

Filters